• Fetck KC Callout
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspective
Weekly Newscast
dvm360 Insights™
dvm360 LIVE!™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Client Handouts
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2022 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Morris Animal Foundation accepting research proposals for feline oncologic advancements

August 3, 2022
dvm360 Staff

Aims to help find innovations in this field as cancer is leading cause of death for cats

Morris Animal Foundation (MAF) is now accepting research proposals to accelerate the field of feline oncology, with a preference for innovations likely to result in substantial diagnostic or therapeutic advances.

According to an organizational release,1 this proposal request is funded by Blue Buffalo, a MAF donor since 2006, and Canadian company Pet Valu through the foundation’s Donor-Inspired Study program.

“Cancer is a leading cause of death in cats, with one in five cats diagnosed with cancer in their lifetimes,” said Janet Patterson-Kane, BVSc, PhD, FRCVS, Morris Animal Foundation chief scientific officer. “Unfortunately, we don’t see as much research dedicated to feline cancer as we do to canine cancer. The Foundation is working to address this imbalance and improve care for our feline companions.”

Common feline cancers include lymphoma, squamous cell carcinoma, fibrosarcoma, injection-site sarcomas, and mammary tumors.1 Outcomes range for cats diagnosed based on cancer type and stage, thus additional research is needed to improve diagnostic tools, treatment options, pain management, and even find cures.

“Blue Buffalo was founded on a promise made to a lovable Airedale named Blue who struggled with cancer, a leading cause of death in pets,” expressed Denise DeVeer, Canada national accounts manager of Blue Buffalo, in the release. “Delivering on that promise to end pet cancer continues to be at the heart of what we do every day as we make the best pet food possible for dogs and cats with high-quality, natural ingredients and support important research to help end the devastating effects of pet cancer.”

“Pet Valu understands the deep connection devoted pet lovers have with their pets and how difficult it is when a pet develops a serious illness,” said Tanbir Grover, chief digital and marketing officer at Pet Valu. “We are so thankful to the devoted pet lovers who helped us raise funds to support research that may advance diagnoses and enhance therapies for pet cancers in the future.”1

Investigators exclusively from Canadian institutions are eligible to apply to this request for proposal, and the research must be conducted in Canada. Research studies focused on other species or from other geographic regions will not be considered. The maximum project duration is 24 months, and the maximum study budget is $52,500 CAD ($41,777 USD). According to the release,1 applications will be reviewed and rated by a scientific advisory board consisting of subject matter experts, and based on impact and scientific rigor.

Reference

Morris Animal Foundation accepting research proposals for feline cancer. News release. Morris Animal Foundation. July 28, 2022. Accessed August 3, 2022. https://www.morrisanimalfoundation.org/article/feline-cancer-research-funding-open

Related Content:

Feline MedicineOncology
Varian Veterinary Oncology to host inaugural 2-day clinical educational program
Varian Veterinary Oncology to host inaugural 2-day clinical educational program
A paradigm shift to leptospirosis as a small dog disease
A paradigm shift to leptospirosis as a small dog disease
Mitigating leptospirosis with vaccines that reduce both transmission and circulation in the bloodstream
Mitigating leptospirosis with vaccines that reduce both transmission and circulation in the bloodstream

Latest News

Are you ready for the Fetch dvm360® Kansas City Block Party?

Mini donkey successfully receives pacemaker to manage fatal heart condition

News wrap-up: This week’s headlines, plus Cincinnati Zoo welcomes baby hippo

Dr Mike Nolan receives 2022 AVMF/EveryCat Health Foundation Research Award

View More Latest News